Daesung Microbiological Labs. Co., Ltd.
Daesung Microbiological Labs. Co., Ltd., headquartered in Uiwang-si, South Korea, is a leading veterinary pharmaceutical manufacturer specializing in the development and production of vaccines, antibiotics, probiotics, and biosecurity solutions for livestock, poultry, aquaculture, and companion animals. Since its establishment, Daesung has been at the forefront of veterinary microbiology and disease prevention, delivering high-quality, research-driven solutions to improve animal health and productivity.
Core Business and Specialization
Daesung Microbiological Labs. focuses on veterinary disease prevention, treatment, and nutritional support through advanced biotechnological research and microbiological applications. The company's core areas of expertise include:
- Animal Vaccines – Development of viral and bacterial vaccines for swine, poultry, cattle, fish, and companion animals.
- Antibiotics and Antibacterials – Broad-spectrum and targeted antibacterial solutions to treat and prevent infectious diseases.
- Parasiticides and Disinfectants – Anthelmintics for parasite control and farm biosecurity solutions.
- Probiotics and Enzyme Products – Gut health-enhancing probiotics and digestive enzyme formulations.
- Nutrient and Therapeutic Supplements – Vitamin and mineral supplements designed to boost immunity, digestion, and metabolic functions.
Daesung is committed to reducing antibiotic dependency by developing next-generation probiotics, immunostimulants, and alternative therapeutics that promote natural disease resistance.
Product and Service Offerings
Daesung Microbiological Labs. provides a comprehensive range of veterinary products, categorized into five key segments:
1. Animal Vaccines
- Swine Vaccines: Protecting against PRRS, PCV2, Mycoplasma, and Classical Swine Fever.
- Poultry Vaccines: Effective solutions for Newcastle Disease, Avian Influenza, and Infectious Bronchitis.
- Canine Vaccines: Immunization against Canine Parvovirus, Distemper, and Rabies.
- Cattle Vaccines: Prevention of Bovine Respiratory Disease and Foot-and-Mouth Disease.
- Fish Vaccines: Addressing bacterial and viral infections in aquaculture systems.
2. Antibiotics and Antibacterials
- Broad-Spectrum Antibiotics: Targeting respiratory and enteric infections in livestock.
- Targeted Antibacterials: Specifically formulated for gram-positive and gram-negative bacterial control.
3. Parasiticides and Disinfectants
- Anthelmintics: Effective deworming solutions for swine, cattle, and poultry.
- Farm Disinfectants: Biosecurity solutions for disease prevention in animal housing facilities.
4. Probiotics and Enzyme Products
- Gut Health Probiotics: Microbial supplements to enhance digestion and improve feed conversion ratios (FCR).
- Digestive Enzymes: Formulations designed to increase nutrient absorption and gut efficiency.
5. Nutrients and Pharmaceuticals
- Vitamin Supplements: Strengthening immune function and metabolic health.
- Mineral Supplements: Ensuring optimal growth and bone development.
- Therapeutic Drugs: Addressing inflammatory, metabolic, and stress-related conditions in livestock.
Market Reach and Export Performance
Daesung Microbiological Labs. has established a strong international presence, with products distributed in over 30 countries, including China, Southeast Asia, the Middle East, Europe, and Latin America.
- Year-on-year export growth of 18%, fueled by the rising demand for animal vaccines and antibiotic alternatives.
- Successfully partnered with over 500 veterinary distributors, feed manufacturers, and livestock integrators.
- Leading supplier of animal health solutions in South Korea, with a dominant market share in swine and poultry vaccines.
Financial Strength and Growth
Daesung Microbiological Labs. has demonstrated steady financial growth, with strong investments in research and development.
- Annual revenue: $85 million USD (2023).
- 10% of total revenue allocated to R&D, ensuring continuous innovation in veterinary biotechnology.
- Increased production capacity by 25% in the last five years to meet global demand.
Certifications and Compliance
Daesung adheres to strict international veterinary standards, ensuring product efficacy, safety, and regulatory compliance. The company holds the following certifications:
- GMP (Good Manufacturing Practices) Certification – Compliance with veterinary pharmaceutical standards.
- ISO 9001 – Quality Management System for consistent product development and manufacturing.
- ISO 22000 – Food Safety Management System for animal nutrition products.
- HACCP (Hazard Analysis and Critical Control Points) – Ensuring biosafety and risk mitigation in vaccine and pharmaceutical production.
- EU and US FDA Compliance – Meeting international regulatory requirements for veterinary health solutions.
Research and Innovation
Daesung Microbiological Labs. operates state-of-the-art R&D facilities, focusing on molecular microbiology, vaccine development, and alternative therapeutics.
- Collaboration with top veterinary research institutions, including the Korea Animal Health Research Institute (KAERI) and Seoul National University Veterinary School.
- Developed patented vaccine delivery technologies, ensuring higher immunogenicity and reduced side effects.
- Investment in precision fermentation and microbial engineering, producing highly effective probiotics and bioactive peptides.
Customer Testimonials
Daesung has earned strong industry recognition for its veterinary solutions, receiving endorsements from farmers, veterinarians, and livestock producers:
- "Daesung’s poultry vaccines have significantly reduced mortality rates in our broiler farm, improving productivity and efficiency." – Poultry Farm Owner, Vietnam
- "Their probiotic feed additives have enhanced gut health and feed conversion ratios, lowering our antibiotic use by 40%." – Swine Nutritionist, China
- "The farm disinfectants from Daesung provide excellent biosecurity, preventing disease outbreaks and ensuring herd health." – Dairy Farm Manager, South Korea
Major Achievements
- Ranked among the Top 5 Veterinary Pharmaceutical Companies in South Korea.
- Awarded the Veterinary Innovation Award 2023 for its advancements in next-generation animal vaccines.
- Expanded production capacity by 25% in response to rising global demand.
- Secured strategic partnerships with global livestock integrators and research institutions.
Daesung Microbiological Labs. Co., Ltd. remains a trusted leader in veterinary pharmaceuticals, delivering science-backed, high-performance solutions that enhance animal health, disease prevention, and livestock productivity worldwide.
